Asgar Ali

6.7k total citations
112 papers, 5.3k citations indexed

About

Asgar Ali is a scholar working on Pharmaceutical Science, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Asgar Ali has authored 112 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Pharmaceutical Science, 22 papers in Molecular Biology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Asgar Ali's work include Advanced Drug Delivery Systems (63 papers), Advancements in Transdermal Drug Delivery (62 papers) and Drug Solubulity and Delivery Systems (21 papers). Asgar Ali is often cited by papers focused on Advanced Drug Delivery Systems (63 papers), Advancements in Transdermal Drug Delivery (62 papers) and Drug Solubulity and Delivery Systems (21 papers). Asgar Ali collaborates with scholars based in India, Saudi Arabia and Pakistan. Asgar Ali's co-authors include Mohd. Aqil, Yasmin Sultana, Abdul Ahad, Syed Sarim Imam, Javed Ali, Sanjula Baboota, Aseem Bhatnagar, Ameeduzzafar Zafar, Gaurav Mittal and Himanshu Gupta and has published in prestigious journals such as Carbohydrate Polymers, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Asgar Ali

110 papers receiving 5.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Asgar Ali 3.7k 1.2k 976 775 629 112 5.3k
Ana Cristina Calpena 2.7k 0.7× 1.0k 0.9× 802 0.8× 813 1.0× 594 0.9× 195 5.3k
Yasmin Sultana 3.7k 1.0× 1.6k 1.3× 639 0.7× 925 1.2× 797 1.3× 174 6.3k
Syed Sarim Imam 3.0k 0.8× 1.4k 1.1× 473 0.5× 931 1.2× 624 1.0× 206 5.8k
Raid G. Alany 2.3k 0.6× 866 0.7× 1.3k 1.4× 616 0.8× 433 0.7× 129 4.6k
Gautam Singhvi 2.5k 0.7× 1.3k 1.1× 465 0.5× 842 1.1× 437 0.7× 151 5.6k
Sara Nicoli 1.6k 0.4× 813 0.7× 534 0.5× 649 0.8× 244 0.4× 100 3.5k
Elena Sánchez‐López 1.3k 0.3× 1.4k 1.1× 491 0.5× 956 1.2× 386 0.6× 126 5.7k
Patrizia Chetoni 1.9k 0.5× 613 0.5× 1.0k 1.1× 365 0.5× 337 0.5× 106 3.2k
Maria Helena Amaral 1.6k 0.4× 1.1k 0.9× 410 0.4× 809 1.0× 862 1.4× 113 4.5k
Sai H. S. Boddu 1.6k 0.4× 1.2k 1.0× 784 0.8× 805 1.0× 281 0.4× 126 4.4k

Countries citing papers authored by Asgar Ali

Since Specialization
Citations

This map shows the geographic impact of Asgar Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asgar Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asgar Ali more than expected).

Fields of papers citing papers by Asgar Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asgar Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asgar Ali. The network helps show where Asgar Ali may publish in the future.

Co-authorship network of co-authors of Asgar Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Asgar Ali. A scholar is included among the top collaborators of Asgar Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asgar Ali. Asgar Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qamar, Zufika, Ali Sartaj, Ozair Alam, et al.. (2025). Docetaxel and quercetin-loaded lipid nanocarrier optimized by quality by design for glioblastoma therapy: a ligand-conjugated and therapeutic repurposing approach. Particulate Science And Technology. 44(2). 212–238.
3.
4.
Ali, Asad, Asad Ali, Mohd. Aqil, et al.. (2024). An overview of phospholipid enriched-edge activator-based vesicle nanocarriers: new paradigms to treat skin cancer. Journal of drug targeting. 33(1). 17–41. 8 indexed citations
5.
Ali, Asgar, et al.. (2024). Exploring role of citrus fruits in comorbid neurodegenerative disorders associated with psoriasis. Metabolic Brain Disease. 40(1). 62–62. 4 indexed citations
6.
Almajidi, Yasir Qasim, et al.. (2023). Binary Ethosomal Gel for Enhanced Transdermal Delivery of Tazarotene: Development, Refinement, in vitro Evaluation, and Skin Penetration Investigations. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 5(1S). 42–50. 1 indexed citations
7.
Qamar, Zufika, Ali Sartaj, Mohammad Kashif Iqubal, et al.. (2023). Combination drug loaded lipid-based nanocarriers as treatment entity for battling glioblastoma multiforme. Journal of Drug Delivery Science and Technology. 87. 104800–104800. 8 indexed citations
8.
Zafar, Ameeduzzafar, et al.. (2023). Development of Forskolin and rutin-loaded polymeric nanoparticles for enhancement of topical ocular delivery: Optimization, in-vitro, ex-vivo, and toxicity evaluation. Journal of Drug Delivery Science and Technology. 82. 104292–104292. 13 indexed citations
9.
Mohammad, Musarrat Husain Warsi, Mohammed A. S. Abourehab, et al.. (2023). Intranasal inorganic cerium oxide nanoparticles ameliorate oxidative stress induced motor manifestations in haloperidol-induced parkinsonism. Inflammopharmacology. 31(5). 2571–2585. 4 indexed citations
10.
Ali, Asgar, et al.. (2023). Hypothesizing the Green Synthesis of Tamoxifen Loaded MagneticNanoparticles for the Treatment of Breast Cancer. Current Molecular Medicine. 24(5). 537–546. 3 indexed citations
11.
Zafar, Ameeduzzafar, Javed Ali, Saba Khan, et al.. (2022). Formulation of Lipid-Based Nanocarriers of Lacidipine for Improvement of Oral Delivery: Box-Behnken Design Optimization, In Vitro , Ex Vivo , and Preclinical Assessment. Assay and Drug Development Technologies. 20(1). 5–21. 9 indexed citations
12.
Imam, Syed Sarim, Abdul Ahad, Mohd. Aqil, et al.. (2017). Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: In-vitro characterization, and in-vivo appraisal. Materials Science and Engineering C. 75. 1198–1205. 72 indexed citations
13.
Musthafa, Mohamed Saiyad, Sadasivam Anbumani, Asgar Ali, et al.. (2017). Ameliorative efficacy of bioencapsulated Chironomous larvae with Shilajit on Zebrafish (Danio rerio) exposed to Ionizing radiation. Applied Radiation and Isotopes. 128. 108–113. 4 indexed citations
14.
Ahmed, Shakeeb, et al.. (2015). In vitroand preclinical assessment of factorial design based nanoethosomes transgel formulation of an opioid analgesic. Artificial Cells Nanomedicine and Biotechnology. 44(8). 1793–1802. 35 indexed citations
15.
Aqil, Mohd., et al.. (2013). Nanoparticles laden in situ gel for sustained ocular drug delivery. Journal of Pharmacy And Bioallied Sciences. 5(2). 162–162. 36 indexed citations
16.
Kalam, Mohd Abul, Yasmin Sultana, Asgar Ali, et al.. (2012). Part II: Enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops. Journal of Biomedical Materials Research Part A. 101A(6). 1828–1836. 46 indexed citations
17.
Gupta, Himanshu, Mohd. Aqil, R. K. Khar, et al.. (2010). Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. Journal of drug targeting. 19(6). 409–417. 111 indexed citations
18.
Mittal, Ashu, Udai Vir Singh Sara, & Asgar Ali. (2009). Formulation and evaluation of monolithic matrix polymer films for transdermal delivery of nitrendipine. Acta Pharmaceutica. 59(4). 383–93. 13 indexed citations
19.
Rastogi, Rachna, Yasmin Sultana, Mohd. Aqil, et al.. (2006). Alginate microspheres of isoniazid for oral sustained drug delivery. International Journal of Pharmaceutics. 334(1-2). 71–77. 137 indexed citations
20.
Sultana, Yasmin, et al.. (2004). A Three-Way Comparative Study on the Efficacy of Twin Sol to Gel Systems and Marketed Eye Drops of Pefloxacin Mesylate. Journal of Ocular Pharmacology and Therapeutics. 20(4). 363–371. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Cristina Calpena Breakdown of academic impact, for papers by Yasmin Sultana Breakdown of academic impact, for papers by Syed Sarim Imam Breakdown of academic impact, for papers by Raid G. Alany Breakdown of academic impact, for papers by Gautam Singhvi Breakdown of academic impact, for papers by Sara Nicoli Breakdown of academic impact, for papers by Elena Sánchez‐López Breakdown of academic impact, for papers by Patrizia Chetoni Breakdown of academic impact, for papers by Maria Helena Amaral Breakdown of academic impact, for papers by Sai H. S. Boddu
Rankless by CCL
2026